Richard M Jensen, DPM
Podiatry · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jensen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$73,535
Medicare paid this office $73,535 for 364 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 139 | $19,981 | $114 |
| Short return visit (20+ min) | 124 | $13,180 | $82 |
| New patient visit (30+ min) | 121 | $11,705 | $97 |
| Removal of noncancer thickened skin growth, 2-4 growths | 25 | $2,384 | $79 |
| Removal of fingernails or toenails, 6 or more nails | 38 | $2,313 | $41 |
See all 10 services
| Return visit (30+ min) | 139 | $19,981 | $114 |
| Short return visit (20+ min) | 124 | $13,180 | $82 |
| New patient visit (30+ min) | 121 | $11,705 | $97 |
| Removal of noncancer thickened skin growth, 2-4 growths | 25 | $2,384 | $79 |
| Removal of fingernails or toenails, 6 or more nails | 38 | $2,313 | $41 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $1,648 | $127 |
| Removal of noncancer thickened skin growth, 1 growth | 22 | $1,517 | $66 |
| New patient visit (15+ min) | 28 | $1,433 | $51 |
| Injection into tendon or ligament | 12 | $701 | $47 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $44 | None |
Procedures Medicare counted
| Removal of nail tissue | 112 | More than 70% of doctors who do this |
| Removal of tissue | 18 | More than 68% of doctors who do this |
| Removal or shaving of skin growth | 82 | More than 83% of doctors who do this |
Who their Medicare patients are
364 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 15% · Women 56% · Also on Medicaid 10% · Health risk score 1.09. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 64% · Diabetes 30% · Coronary heart disease 28% · Chronic kidney disease 23% · Depression 20% · Atrial fibrillation 17% · Cancer 15% · Heart failure 14% · Dementia 9% · COPD 8% · Stroke 6%.
The office billed $292,207, Medicare allowed $99,023 and paid $73,535; for 803 services of 58 kinds; $94 of it was for drugs given in the office and $73,441 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 364 | 803 | 76 | 1.09 | $292,207 | $73,535 |
| 2023 | 318 | 712 | 77 | 1.12 | $219,866 | $62,203 |
| 2022 | 323 | 805 | 77 | 1.04 | $270,084 | $74,409 |
| 2021 | 325 | 892 | 77 | 1.20 | $266,555 | $79,722 |
| 2020 | 258 | 603 | 78 | 1.26 | $167,062 | $46,755 |
| 2019 | 306 | 742 | 76 | 1.19 | $226,880 | $58,626 |
| 2018 | 336 | 836 | 76 | 1.19 | $231,300 | $59,658 |
| 2017 | 307 | 790 | 75 | 1.37 | $217,346 | $56,947 |
| 2016 | 306 | 802 | 75 | 1.23 | $237,510 | $62,131 |
| 2015 | 293 | 730 | 76 | 1.22 | $205,874 | $57,733 |
| 2014 | 275 | 704 | 75 | 1.05 | $192,198 | $50,624 |
| 2013 | 250 | 668 | 76 | 1.30 | $186,825 | $48,508 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 136 | $15,464 | $84 |
| Return visit (30+ min) | 91 | $13,523 | $121 |
| New patient visit (30+ min) | 76 | $7,676 | $101 |
| Removal of noncancer thickened skin growth, 1 growth | 32 | $2,582 | $72 |
| Removal of noncancer thickened skin growth, 2-4 growths | 25 | $2,539 | $85 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $2,494 | $131 |
| New patient visit (15+ min) | 38 | $2,425 | $64 |
| Removal of fingernails or toenails, 6 or more nails | 33 | $1,787 | $41 |
| Aspiration and/or injection of fluid from small joint | 14 | $818 | $45 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 11 | $78 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $45 | None |
2022: 10 services
| Return visit (30+ min) | 99 | $15,245 | $119 |
| Short return visit (20+ min) | 122 | $12,976 | $82 |
| New patient visit (30+ min) | 101 | $9,433 | $93 |
| Repair of multiple toe tendons | 13 | $5,251 | $263 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $3,507 | $135 |
| Removal of fingernails or toenails, 6 or more nails | 46 | $3,155 | $43 |
| Removal of noncancer thickened skin growth, 1 growth | 38 | $3,091 | $72 |
| Removal of noncancer thickened skin growth, 2-4 growths | 23 | $2,519 | $84 |
| New patient visit (15+ min) | 34 | $2,314 | $68 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $38 | None |
2021: 12 services
| Return visit (30+ min) | 103 | $15,410 | $121 |
| Short return visit (20+ min) | 122 | $14,553 | $82 |
| New patient visit (30+ min) | 81 | $8,552 | $106 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $5,221 | $134 |
| Removal of fingernails or toenails, 6 or more nails | 56 | $4,520 | $44 |
| Removal of noncancer thickened skin growth, 2-4 growths | 30 | $3,996 | $75 |
| New patient visit (15+ min) | 47 | $3,217 | $68 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $2,702 | $73 |
| Short return visit | 11 | $679 | $57 |
| Removal of fingernails or toenails, 1-5 nails | 14 | $513 | $34 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 11 | $130 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $49 | None |
2020: 8 services
| Return visit (30+ min) | 60 | $7,797 | $103 |
| New patient visit (30+ min) | 82 | $7,774 | $95 |
| Short return visit (20+ min) | 89 | $7,477 | $69 |
| Removal of fingernails or toenails, 6 or more nails | 54 | $3,757 | $43 |
| New patient visit (15+ min) | 39 | $2,563 | $66 |
| Removal of noncancer thickened skin growth, 2-4 growths | 23 | $2,357 | $74 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $2,032 | $120 |
| Removal of noncancer thickened skin growth, 1 growth | 22 | $1,610 | $64 |
2019: 10 services
| Return visit (30+ min) | 101 | $11,716 | $96 |
| New patient visit (30+ min) | 89 | $8,346 | $94 |
| Short return visit (20+ min) | 88 | $8,128 | $68 |
| Removal of fingernails or toenails, 6 or more nails | 65 | $4,854 | $41 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $3,156 | $117 |
| Removal of noncancer thickened skin growth, 2-4 growths | 28 | $2,524 | $65 |
| New patient visit (15+ min) | 27 | $1,891 | $70 |
| Removal of noncancer thickened skin growth, 1 growth | 25 | $1,630 | $53 |
| Short return visit | 13 | $580 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $40 | None |
2018: 11 services
| Return visit (30+ min) | 148 | $18,063 | $92 |
| New patient visit (30+ min) | 121 | $10,942 | $90 |
| Short return visit (20+ min) | 66 | $5,224 | $60 |
| Removal of fingernails or toenails, 6 or more nails | 60 | $4,589 | $42 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $3,277 | $117 |
| Removal of noncancer thickened skin growth, 2-4 growths | 27 | $2,680 | $55 |
| Removal of noncancer thickened skin growth, 1 growth | 18 | $1,150 | $46 |
| New patient visit (15+ min) | 17 | $1,065 | $63 |
| Injection into tendon or ligament | 19 | $1,018 | $48 |
| Aspiration and/or injection of fluid from small joint | 13 | $545 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $109 | None |
2017: 11 services
| Return visit (30+ min) | 134 | $15,637 | $94 |
| New patient visit (30+ min) | 93 | $8,370 | $90 |
| Short return visit (20+ min) | 79 | $6,917 | $63 |
| Removal of fingernails or toenails, 6 or more nails | 51 | $4,306 | $40 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $2,696 | $108 |
| New patient visit (15+ min) | 28 | $1,691 | $60 |
| Removal of noncancer thickened skin growth, 2-4 growths | 15 | $1,238 | $56 |
| Removal of noncancer thickened skin growth, 1 growth | 19 | $1,081 | $45 |
| Short return visit | 13 | $567 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 15 | $117 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $72 | None |
2016: 11 services
| Return visit (30+ min) | 111 | $14,122 | $97 |
| New patient visit (30+ min) | 105 | $10,101 | $96 |
| Short return visit (20+ min) | 96 | $8,057 | $63 |
| Removal of fingernails or toenails, 6 or more nails | 48 | $4,477 | $41 |
| Permanent removal fingernail or toenail | 11 | $1,965 | $164 |
| New patient visit (15+ min) | 20 | $1,336 | $67 |
| Removal of noncancer thickened skin growth, 2-4 growths | 15 | $1,238 | $54 |
| Removal of noncancer thickened skin growth, 1 growth | 21 | $845 | $40 |
| Aspiration and/or injection of fluid from small joint | 14 | $811 | $48 |
| Short return visit | 13 | $790 | $40 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 16 | $125 | None |
2015: 10 services
| New patient visit (30+ min) | 95 | $9,326 | $98 |
| Short return visit (20+ min) | 98 | $8,891 | $71 |
| Return visit (30+ min) | 55 | $6,526 | $102 |
| Removal of fingernails or toenails, 6 or more nails | 54 | $4,892 | $43 |
| Permanent removal fingernail or toenail | 14 | $3,799 | $211 |
| Removal of noncancer thickened skin growth, 2-4 growths | 27 | $2,305 | $55 |
| New patient visit (15+ min) | 30 | $2,100 | $70 |
| Short return visit | 23 | $1,239 | $41 |
| Removal of noncancer thickened skin growth, 1 growth | 20 | $982 | $49 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $73 | None |
2014: 8 services
| Short return visit (20+ min) | 120 | $11,423 | $65 |
| New patient visit (30+ min) | 112 | $10,237 | $91 |
| Removal of fingernails or toenails, 6 or more nails | 46 | $4,964 | $42 |
| Removal of noncancer thickened skin growth, 2-4 growths | 23 | $2,671 | $55 |
| Return visit (30+ min) | 21 | $2,055 | $93 |
| Short return visit | 27 | $1,287 | $39 |
| New patient visit (15+ min) | 12 | $780 | $65 |
| Removal of noncancer thickened skin growth, 1 growth | 12 | $706 | $47 |
2013: 6 services
| Short return visit (20+ min) | 106 | $10,108 | $65 |
| New patient visit (30+ min) | 95 | $9,265 | $98 |
| Removal of fingernails or toenails, 6 or more nails | 53 | $5,879 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 28 | $3,713 | $55 |
| New patient visit (15+ min) | 20 | $1,138 | $57 |
| Short return visit | 24 | $995 | $38 |
Drugs they prescribed that Part D paid
$1,073
Pharmacies billed $1,073 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 18% of their Part D prescriptions (11 of 63) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
63 generic and 0 brand-name prescriptions · $1,073 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Terbinafine | 13 | $256 | $20 |
Year by year
| 2024 | 63 | 38 | 18% (11) | 0% | $1,073 |
| 2023 | 38 | 25 | None | 0% | $1,011 |
| 2022 | 56 | 35 | 29% (16) | 0% | $1,029 |
| 2021 | 51 | 27 | None | None | $912 |
| 2020 | 38 | 24 | None | 0% | $968 |
| 2019 | 38 | 23 | None | None | $3,342 |
| 2018 | 49 | 28 | None | None | $6,004 |
| 2017 | 56 | 30 | None | None | $6,136 |
| 2016 | 100 | 43 | 21% (21) | None | $7,272 |
| 2015 | 97 | 49 | 13% (13) | None | $5,095 |
| 2014 | 79 | 38 | 28% (22) | None | $4,012 |
| 2013 | 77 | 30 | 35% (27) | None | $1,591 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Diclofenac | 12 | $239 | $20 |
2016: 2 drugs
| Mupirocin | 15 | $2,358 | $157 |
| Hydrocodone-Acetaminophen | 13 | $168 | $13 |
2015: 2 drugs
| Econazole Nitrate | 12 | $2,691 | $224 |
| Hydrocodone-Acetaminophen | 12 | $130 | $11 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 17 | $158 | $9 |
2013: 3 drugs
| Hydrocodone-Acetaminophen | 27 | $265 | $10 |
| Mupirocin | 12 | $164 | $14 |
| Gabapentin | 12 | $156 | $13 |
Money from drug and device companies
$174 in 2025
| 2025 | 1 | 4 | None | $174 |
| 2024 | 1 | 2 | None | $496 |
| 2023 | 1 | 1 | None | $150 |
| 2022 | 1 | 2 | None | $1,225 |
| 2021 | 1 | 1 | None | $125 |
| 2020 | 1 | 1 | None | $30 |
| 2019 | 3 | 4 | None | $2,372 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Fuseforce | $174 | 4 payments
|
See all 4 published payments
| Stryker | Meals · 2025-11-13 | Prostep Mica | $22 |
| Stryker | Meals · 2025-07-30 | Dart-Fire | $21 |
| Stryker | Meals · 2025-07-24 | Fuseforce | $110 |
| Stryker | Meals · 2025-07-01 | Flexband | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $496
| Stryker | Augment Injectable | $496 | 2 payments
|
2023: $150
| Evolution Surgical | None | $150 | 1 payment
|
2022: $1,225
| Evolution Surgical | None | $1,225 | 2 payments
|
2021: $125
| Evolution Surgical | None | $125 | 1 payment
|
2020: $30
| Evolution Surgical | None | $30 | 1 payment
|
2019: $2,372
| Evolution Surgical | None | $2,316 | 2 payments
|
| Arthrex | Distal Extremities Implants Fracture Management Distal Tibia | $41 | 1 payment
|
| In2Bones USA | Colink | $15 | 1 payment
|
Professional record
- NPI
- 1811077498
- Licence
- CA E4009
- Trained
- California School of Podiatric Medicine, 1994
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-10-17
- NPI last updated
- 2011-12-02
This is when the NPI record was last certified, not a medical board exam.